Beta-1,3/1,6-D-Glucan Ganoderma Lucidum on Non-infectious and Idiopathic Uveitis
Status:
Recruiting
Trial end date:
2021-12-01
Target enrollment:
Participant gender:
Summary
To investigate the effect of Beta-1,3/1,6-D-Glucan from mycelium extract of Indonesian
Ganoderma lucidum as an adjuvant to methylprednisolone for non-infectious and idiopathic
uveitis